LINCOLN — Nebraska’s Nitrogen Reduction Incentive Act (NiRIA) program will provide financial incentives to farmers who reduce nitrogen fertilizer use. The Nebraska Department of Water, Energy and ...

Abstract: Contribution: Results and conclusions on the use of a hybrid Project-Based Learning (PBL) approach to teaching programming in a higher education computing department. Background: PBL is a ...

Google is now offering its store widget in three levels that you can integrate into your website, showcasing ratings and policies. Google now offers three versions of its store widget that merchants ...

ICE Protests in Portland Lead to Arrests Nightly protests against Immigration and Customs Enforcement continued at the ICE building in southwest Portland, leading June 16 to a confrontation between ...

Abstract: Hybrid electric vehicles (HEVs) rely on energy management strategies (EMSs) to achieve optimal fuel economy. However, both model- and learning-based EMSs have their respective limitations ...

Oracle has released JDK (Java Development Kit) 25, the first long term support (LTS) version since JDK 21 two years ago. New features include beginner-friendly compact source files, succinct module ...

Critics are calling the City of Vaughan's decision to scrap its speed camera program short-sighted, saying the cameras were effective at reducing speeding. Councillors voted Monday to halt the program ...

HUNTSVILLE, Ala. (WAFF) - James Clemens High School has been fined and forfeited one game over a violation of the Alabama High School Athletic Association’s academic rule. The school’s football ...

PINE BLUFF, Ark. — A Pine Bluff pharmacy chain owes a combined $3.5 million to a hospital and community health center in debts related to a federal discount drug program, according to bankruptcy ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Kenneth Harris, a NASA veteran who worked on ...

The FDA's new program could expedite Orforglipron's approval, reducing review time to 1-2 months for high-burden condition treatments. Orforglipron, a non-peptide oral GLP-1 receptor agonist, has ...